“Efficacy, Health-Related Outcomes, and Safety of Ixekizumamb for up to Five Years of Open-Label Treatment in a Phase 2 Study in Chronic Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s12. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/174.